These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7006487)

  • 1. [Hormone therapy in advanced forms of carcinoma of the endometrium: analysis and prospects].
    La Vecchia C; Franceschi S; Gritti P; Valente I
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):181-6. PubMed ID: 7006487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R; Jänne O; Kauppila A
    Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonotherapy of carcinoma of the endometrium].
    Sismondi P; Barengo R; Zola P; Giai M; De Fabiani E
    Minerva Ginecol; 1986 Oct; 38(10):815-23. PubMed ID: 3808413
    [No Abstract]   [Full Text] [Related]  

  • 6. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of progestational agents in the management of metastatic carcinoma of the endometrium.
    Kistner RW; Griffiths CT
    Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
    Bernardo-Strada MR; Imparato E; Aspesi G; Pavesi L; Robustelli Della Cuna G
    Minerva Med; 1980 Nov; 71(44):3241-6. PubMed ID: 7454090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
    Edmonson JH; Krook JE; Hilton JF; Long HJ; Cullinan SA; Everson LK; Malkasian GD
    Cancer Treat Rep; 1986 Aug; 70(8):1019-20. PubMed ID: 3731147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
    Ide P; Bonte J
    Br J Cancer; 1974 Aug; 30(2):175. PubMed ID: 4419502
    [No Abstract]   [Full Text] [Related]  

  • 15. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Kauppila A
    Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.